1: 2 bonus from Orchid Chemicals
18 Jul 2005
Chennai:
The board of directors of the Rs34.14-crore equity based
bulk drug company, Orchid Chemicals & Pharmaceuticals
Limited, have approved bonus shares issue of one share
for every two shares held. At the end of last fiscal the
company had reserves to the tune of Rs437 crore.
During the first quarter of the current fiscal the company has posted a turnover of Rs170.25 crore and a net profit of Rs7.33 crore as compared to a turnover Rs174.26 crore and Rs4.69 crore declared for the corresponding period in 2004.
However the first quarter turnover and profit are lower than the turnover (Rs178.10 crore) and profit (Rs16.59 crore) declared during the previous quarter ended 31st March 2005.
Latest articles
.webp)
Featured articles
Shifting terminals: Why global travelers are rethinking trips to the United States
By Cygnus | 09 Mar 2026
Global travel patterns are shifting as costs rise, visa delays persist and competition grows. Here’s why many travelers are rethinking trips to the United States in 2026.
Safety over scale: The Middle East conflict forces a pause in Indian tech expansion
By Axel Miller | 05 Mar 2026
Autonomous vehicle firms pause Abu Dhabi and Dubai operations amid Middle East conflict. Will Indian tech projects pivot to GIFT City and Bangalore?
The energy island: Why Big Tech is building its own power systems for the AI era
By Cygnus | 04 Mar 2026
AI data centers are reshaping the energy market as companies like Amazon, Microsoft and Google invest in dedicated power generation to support massive computing deman
The great memory squeeze: Why your next RAM upgrade could cost more
By Axel Miller | 02 Mar 2026
Rising AI infrastructure demand is tightening global memory supply, driving higher RAM prices for PCs and smartphones and reshaping the semiconductor cycle.
The agentic shift: re-architecting business for the 2026 autonomy cycle
By Cygnus | 26 Feb 2026
From chip competition to IT pricing models, the rise of agentic AI is transforming how companies build, deploy, and monetize technology.
The mainframe moment: how AI-driven modernization is reshaping the COBOL economy
By Axel Miller | 24 Feb 2026
New AI coding tools are accelerating legacy system modernization, raising opportunities and risks for banks, enterprises, and the IT services industry.
The concrete cloud: India’s $250 billion bet on the physical foundations of AI
By Cygnus | 23 Feb 2026
India pivots to AI's physical layer with $250B in pledges for chips and data centers to lead the new era of 'Agentic Commerce.' Read the full report.
The $250 billion pivot: how 2026 became the year AI paid the rent
By Cygnus | 18 Feb 2026
2026 marks the shift from AI “promise” to “profitability.” Explore how India’s sovereign compute and Infosys’s revenue metrics are defining a $250B market pivot.
The analog antidote: perception, reality, and the "Windows crisis" narrative
By Cygnus | 17 Feb 2026
Viral claims of a Windows collapse contrast with market data showing a slower shift as enterprises weigh AI, hardware costs, and legacy systems.
Latest articles
